NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI of $40.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInTradingSecurities · last filed 2026-05-14
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in debt securities, trading, and equity securities, fv-ni for the quarter ending 2026-03-31 was $40.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in debt securities, trading, and equity securities, fv-ni for the quarter ending 2025-03-31 was -$4.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in debt securities, trading, and equity securities, fv-ni for fiscal 2025 was $46.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in debt securities, trading, and equity securities, fv-ni for fiscal 2024 was -$56.00K.
| Period end | Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI 3 month | Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI 12 month |
|---|---|---|
| 2026-03-31 | $40.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $46.00K 10-K · filed 2026-03-31 | |
| 2025-03-31 | -$4.00K 10-Q · filed 2026-05-14 | |
| 2024-12-31 | -$56.00K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |